Skip to main content

Ground breaking research finds ‘Cinderella’ of the medicinal plant world could be the answer to better breast cancer treatment

Ground breaking research finds ‘Cinderella’ of the medicinal plant world could be the answer to better breast cancer treatment

  • Date30 October 2020

A plant which had previously been dismissed as not being medically useful, could prove to be a hero in disguise, after scientists discovered it not only stops the growth of breast cancer cells but does not affect normal cells – a potential first for future cancer chemotherapy treatment.

The Waiting Room - cancer cells.png

The ground breaking research by the team of Professor Alessandra Devoto at Royal Holloway, University of London, in collaboration with Dr Amanda Harvey at Brunel University London, and Professor Nicholas Smirnoff at University of Exeter, incubated the Arabidopsis thaliana leaves, treated with the plant hormone Jasmonate (a substance discovered in jasmine that boosts plant responses to stress), with breast cancer cells.

They found that that although the cancer cells stopped growing, the normal cells remained unaffected. This is significant as use of the plant in breast cancer treatment could potentially lead to a quicker recovery time and less secondary effects for patients subjected to chemical treatment.

They have also discovered molecular mechanisms associated with the changes in the breast cancer cells that will allow development of further new treatments.

Professor Devoto, from the Department of Biological Sciences at Royal Holloway, has been conducting this research since 2006 and has just published a paper on the findings.

She said: “Along with my colleagues from Brunel and Exeter, I am truly excited to have discovered the amazing impact this unassuming plant has on breast cancer cells. It just proves that even plants with a non-medicinal pedigree can work for cancer treatment.

“The plant is very much like the ‘Cinderella’ of the medicinal plant world – no one thought it was so special, but it has shown its true colours via our research. The discovery has important implications in developing treatments for cancer as well as other diseases.”

Dr Harvey and Professor Smirnoff added: “Combined with recent progress in metabolic engineering and biotechnology, our approach will also facilitate production and analysis of bioactivities of valuable metabolites from plants on industrial scales.

“We are looking forward to continuing our collaboration with Professor Devoto to identify the plant-derived chemicals that interfere with breast cancer cells as well as with other diseases and to progress this research by gathering more funding to benefit society more widely.”

Explore Royal Holloway

Get help paying for your studies at Royal Holloway through a range of scholarships and bursaries.

There are lots of exciting ways to get involved at Royal Holloway. Discover new interests and enjoy existing ones

Heading to university is exciting. Finding the right place to live will get you off to a good start

Whether you need support with your health or practical advice on budgeting or finding part-time work, we can help

Discover more about our 21 departments and schools

Find out why Royal Holloway is in the top 25% of UK universities for research rated ‘world-leading’ or ‘internationally excellent’

They say the two most important days of your life are the day you were born, and the day you find out why

Discover world-class research at Royal Holloway

Discover more about who we are today, and our vision for the future

Royal Holloway began as two pioneering colleges for the education of women in the 19th century, and their spirit lives on today

We’ve played a role in thousands of careers, some of them particularly remarkable

Find about our decision-making processes and the people who lead and manage Royal Holloway today